Skip to Main Content

ADVERTISEMENT

SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Journal of Hepatology

EASL

Home
Editor's Choice
Articles and Issues
Collections
Manuscript
Journal Info
News and Media
Subscribe
EASL
More Periodicals

Advanced searchSave search

Please enter a term before submitting your search.

Submit
Log in
Register
Log in
- Submit
- Log in
Subscribe
Claim

Issue cover for Volume 68, Issue 5

May 2018

Volume 68Issue 5p869-1106, e33-e48

Issue cover for Volume 68, Issue 5

Current Issue
Articles in Press
Archive
- Archive

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Editorial Board

Published in issue: May 2018

i

PDF

EASL monothematic conference: Gut–liver axis, Leuven, Belgium, 2018

Published in issue: May 2018

ii

PDF

EASL NAFLD Summit 2018, Geneva, Switzerland

Published in issue: May 2018

iii

PDF

EASL clinical school: Abdominal sonography, Rotterdam, Netherlands, 2018

Published in issue: May 2018

iv

PDF

The International Liver Congress^TM, Vienna, Austria, 2019

Published in issue: May 2018

v

PDF

Contents

Published in issue: May 2018

vii-ix

PDF

From the Editor's Desk

From the Editor’s desk....

From the Editor’s desk....

May 2018

Richard Moreau,
Ramon Bataller,
Thomas Berg,
Jessica Zucman-Rossi,
Rajiv Jalan

Published in issue: May 2018

p869-872

Full-Text HTML
PDF

JHEP at a Glance

JHEP at a glance (May 2018)

Published in issue: May 2018

e33-e47

Online Only

PDF

Editorials

«The times they are a’changin’» – Positioning the European Association for the Study of the Liver in the changing landscape of hepatology

«The times they are a’changin’» – Positioning the European Association for the Study of the Liver in the changing landscape of hepatology

Tom H. Karlsen,
Frank Tacke

Published online: February 27, 2018

p873-875

Full-Text HTML
PDF

EASL Recognition Award Recipient 2018: Prof. Didier Samuel

EASL Recognition Award Recipient 2018: Prof. Didier Samuel

Daniel Shouval

Published in issue: May 2018

p876-877

Full-Text HTML
PDF

EASL Recognition Award Recipient 2018: Prof. Mario Mondelli

EASL Recognition Award Recipient 2018: Prof. Mario Mondelli

Michael P. Manns

Published in issue: May 2018

p878-880

Full-Text HTML
PDF

EASL International Recognition Award Recipient 2018: Prof. Anna Lok

EASL International Recognition Award Recipient 2018: Prof. Anna Lok

Marc G. Ghany

Published in issue: May 2018

p881-882

Full-Text HTML
PDF

For whom the interferons toll – TLR7 mediated boosting of innate and adaptive immunity against chronic HBV infection

For whom the interferons toll – TLR7 mediated boosting of innate and adaptive immunity against chronic HBV infection

Bertram Bengsch,
Robert Thimme

Published online: February 02, 2018

p883-886

Full-Text HTML
PDF
Supplemental Materials

Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango

Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango

M.J. Coenraad,
R. Porcher,
F. Bendtsen

Published online: February 17, 2018

p887-889

Full-Text HTML
PDF
Supplemental Materials

New insights into NAFLD and subclinical coronary atherosclerosis

Lisa B. VanWagner

Published online: February 02, 2018

p890-892

Full-Text HTML
PDF
Supplemental Materials

Relaxing access to liver transplantation with living donation: A foolish move or a time to change?

John G. O'Grady

Published online: December 02, 2017

p893-894

Full-Text HTML
PDF
Supplemental Materials

Research Articles

Viral Hepatitis

Resistance analysis in patients with genotype 1–6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Resistance analysis in patients with genotype 1–6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Christophe Hezode,
Nancy Reau,
Evguenia S. Svarovskaia,
...
Jacqueline G. O'Leary,
Stephen D. Shafran,
Stefan Zeuzem

Published online: December 05, 2017

p895-903

Full-Text HTML
PDF
Supplemental Materials

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis

Jonas Söderholm,
Charlotta Millbourn,
Katharina Büsch,
...
Robert Schvarcz,
Karin Lindahl,
Annette Bruchfeld

Published online: December 09, 2017

p904-911

Open Access

Full-Text HTML
PDF
Supplemental Materials

Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells

Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells

Li Li,
Vivian Barry,
Stephane Daffis,
...
Robert E. Lanford,
William E. Delaney IV,
Simon P. Fletcher

Published online: December 13, 2017

p912-921

Full-Text HTML
PDF
Supplemental Materials

Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism

Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism

Congrong Niu,
Li Li,
Stephane Daffis,
...
Fabien Zoulim,
William E. Delaney IV,
Simon P. Fletcher

Published online: December 13, 2017

p922-931

Full-Text HTML
PDF
Supplemental Materials

Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020

Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020

Nick Scott,
Sigurður Ólafsson,
Magnús Gottfreðsson,
...
Ubaldo Benitez Hernandez,
Guðrún Sigmundsdóttir,
Margaret Hellard

Published online: December 20, 2017

p932-939

Full-Text HTML
PDF
Supplemental Materials

Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C

Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C

Javier Ampuero,
Carlota Jimeno,
Rosa Quiles,
...
José María Navarro,
Javier Salmerón,
Manuel Romero-Gómez

Published online: December 27, 2017

p940-948

Full-Text HTML
PDF
Supplemental Materials

Cirrhosis

Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis

Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis

Laura Turco,
Guadalupe Garcia-Tsao,
Ilenia Magnani,
...
Rosario Rossi,
Erica Villa,
Filippo Schepis

Published online: January 10, 2018

p949-958

Full-Text HTML
PDF
Supplemental Materials

Cancer

Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations

Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations

Christopher P. Wardell,
Masashi Fujita,
Toru Yamada,
...
Satoshi Hirano,
Toru Nakamura,
Hidewaki Nakagawa

Published online: January 19, 2018

p959-969

Open Access

Full-Text HTML
PDF
Supplemental Materials

Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial

Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial

Hai-Dong Zhu,
Jin-He Guo,
Ming Huang,
...
Chang Su,
Li Chen,
Gao-Jun Teng

Published online: January 10, 2018

p970-977

Full-Text HTML
PDF
Supplemental Materials

Effects of the gut–liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver

Effects of the gut–liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver

Lorenzo A. Orci,
Stéphanie Lacotte,
Vaihere Delaune,
...
Laura Rubbia-Brandt,
Philippe Morel,
Christian Toso

Published online: January 10, 2018

p978-985

Full-Text HTML
PDF
Supplemental Materials

Molecular and Cell Biology

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation

Nadine Gehrke,
Nadine Hövelmeyer,
Ari Waisman,
...
Marcus A. Wörns,
Peter R. Galle,
Jörn M. Schattenberg

Published online: January 21, 2018

p986-995

Full-Text HTML
PDF
Supplemental Materials

Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling

Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling

Kateryna Levada,
Nurdan Guldiken,
Xiaoji Zhang,
...
Marianne Ziol,
Christian Trautwein,
Pavel Strnad

Published online: January 10, 2018

p996-1005

Full-Text HTML
PDF
Supplemental Materials

Cholestasis and Autoimmune Diseases

Plectin controls biliary tree architecture and stability in cholestasis

Plectin controls biliary tree architecture and stability in cholestasis

Marketa Jirouskova,
Katerina Nepomucka,
Gizem Oyman-Eyrilmez,
...
Radislav Sedlacek,
Gerhard Wiche,
Martin Gregor

Published online: December 19, 2017

p1006-1017

Full-Text HTML
PDF
Supplemental Materials

Genetic and Metabolic Diseases

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study

Seung Bum Lee,
Gyung-Min Park,
Jong-Young Lee,
...
Hong-Kyu Kim,
Jaewon Choe,
Han Chu Lee

Published online: December 20, 2017

p1018-1024

Full-Text HTML
PDF
Supplemental Materials

Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification

Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification

Maja Thiele,
Vanessa Rausch,
Gabriele Fluhr,
...
Bjørn Madsen,
Aleksander Krag,
Sebastian Mueller

Published online: January 15, 2018

p1025-1032

Full-Text HTML
PDF
Supplemental Materials

Reviews

The molecular functions of hepatocyte nuclear factors – In and beyond the liver

The molecular functions of hepatocyte nuclear factors – In and beyond the liver

Hwee Hui Lau,
Natasha Hui Jin Ng,
Larry Sai Weng Loo,
Joanita Binte Jasmen,
Adrian Kee Keong Teo

Published online: November 23, 2017

p1033-1048

Full-Text HTML
PDF
Supplemental Materials

Development of the liver: Insights into organ and tissue morphogenesis

Development of the liver: Insights into organ and tissue morphogenesis

Elke A. Ober,
Frédéric P. Lemaigre

Published online: January 12, 2018

p1049-1062

Full-Text HTML
PDF
Supplemental Materials

Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

Thomas Jensen,
Manal F. Abdelmalek,
Shelby Sullivan,
...
Miguel A. Lanaspa,
Anna Mae Diehl,
Richard J. Johnson

Published online: February 03, 2018

p1063-1075

Full-Text HTML
PDF
Supplemental Materials

Special Sections

Controversies in Hepatology

Should living donor liver transplantation be an option when deceased donation is not?

Should living donor liver transplantation be an option when deceased donation is not?

Sarah R. Lieber,
Thomas D. Schiano,
Rosamond Rhodes

Published online: October 31, 2017

p1076-1082

Full-Text HTML
PDF
Supplemental Materials

Hepatology Snapshot

Role of bile acids in the gut-liver axis

Role of bile acids in the gut-liver axis

Kai Markus Schneider,
Stefanie Albers,
Christian Trautwein

Published online: March 05, 2018

p1083-1085

Full-Text HTML
PDF

Letters to the Editor

Endothelial JAK2V617F does not enhance liver lesions in mice with Budd-Chiari syndrome

Endothelial JAK2^V617F does not enhance liver lesions in mice with Budd-Chiari syndrome

Johanne Poisson,
Moira B. Hilscher,
Marion Tanguy,
...
Dominique Valla,
Vijay H. Shah,
Pierre-Emmanuel Rautou

Published online: January 19, 2018

p1086-1087

Full-Text HTML
PDF
Supplemental Materials

Visualization of the therapeutic efficacy of a gene correction approach in Wilson’s disease by laser-ablation inductively coupled mass spectrometry

Visualization of the therapeutic efficacy of a gene correction approach in Wilson’s disease by laser-ablation inductively coupled mass spectrometry

Daniel Moreno,
Oihana Murillo,
Cristina Gazquez,
...
Ricarda Uerlings,
Gloria Gonzalez-Aseguinolaza,
Ralf Weiskirchen

Published online: January 06, 2018

p1088-1090

Full-Text HTML
PDF
Supplemental Materials

Studies of macrophage therapy for cirrhosis – From mice to men

James A. Thomas,
Prakash Ramachandran,
Stuart J. Forbes

Published online: January 06, 2018

p1090-1091

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Studies of macrophage therapy for cirrhosis – From mice to men”

Pengfei Ma,
Hua Han,
Hongyan Qin

Published online: January 06, 2018

p1091-1093

Full-Text HTML
PDF
Supplemental Materials

The role of NAFLD in extrahepatic malignancies: The importance of ruling out the effect of obesity

Bo Zheng,
Yan-Jing Zhu,
Hong-Yang Wang,
Lei Chen

Published online: January 19, 2018

p1093-1094

Full-Text HTML
PDF
Supplemental Materials

Reply to: “The role of NAFLD in extrahepatic malignancies: The importance of ruling out the effect of obesity”

Gi-Ae Kim,
Han Chu Lee,
Min-Ju Kim

Published online: January 19, 2018

p1094-1095

Full-Text HTML
PDF
Supplemental Materials

Association between beverage consumption and liver fibrosis

Hanwei Huang,
Yisheng Huang

Published online: January 06, 2018

p1095-1096

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Association between beverage consumption and liver fibrosis”

Louise J.M. Alferink,
Jessica C. Kiefte-de Jong,
Sarwa Darwish Murad

Published online: January 06, 2018

p1096-1098

Full-Text HTML
PDF
Supplemental Materials

“Who killed JR”: Chronic hepatitis C or alcohol use disorders?

“Who killed JR”: Chronic hepatitis C or alcohol use disorders?

Michaël Schwarzinger,
Jürgen Rehm,
Vincent Mallet

Published online: December 30, 2017

p1098-1099

Full-Text HTML
PDF
Supplemental Materials

Reply to: “‘Who killed JR’: Chronic hepatitis C or alcohol use disorders?”

Maryam Alavi,
Matthew G. Law,
Gregory J. Dore

Published online: December 29, 2017

p1099-1100

Full-Text HTML
PDF
Supplemental Materials

Liver resection for BCLC 0-A stage hepatocellular carcinoma: Does the time to surgery not impact the prognosis?

Youliang Pei,
Xiaoping Chen,
Wanguang Zhang

Published online: February 03, 2018

p1101

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Liver resection for BCLC 0-A stage hepatocellular carcinoma: Does the time to surgery not impact the prognosis”

Reply to: “Liver resection for BCLC 0-A stage hepatocellular carcinoma: Does the time to surgery not impact the prognosis”

Chetana Lim,
Chady Salloum,
Daniel Azoulay

Published online: February 01, 2018

p1102

Full-Text HTML
PDF
Supplemental Materials

Stop-and-watch strategy after cessation of nucleos(t)ide analogue therapy in HBeAg-negative patients

Yun-Fan Liaw

Published online: February 04, 2018

p1102-1104

Full-Text HTML
PDF
Supplemental Materials

Reply to: “Stop-and-watch strategy after cessation of nucleos(t)ide analogue therapy in HBeAg-negative patients”

Thomas Berg,
Jörg Petersen
on behalf of the FINITE [First investigation in stopping TDF treatment after long-term virological suppression in HBeAg-negative chronic hepatitis B] study authors

Published online: February 04, 2018

p1104-1105

Full-Text HTML
PDF
Supplemental Materials

Results per page:50

1
2

Login to your account

Email/Username

Password

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

The content on this site is intended for healthcare professionals.

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

RELX